Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

SWTX SpringWorks Therapeutics

28.090
-0.130-0.46%
Close 10/05 16:00 ET
28.0900.0000.00%
Post Mkt Price 10/05 16:07 ET
High
28.560
Open
27.640
Turnover
14.64M
Low
27.440
Pre Close
28.220
Volume
521.77K
Market Cap
1.45B
P/E(TTM)
Loss
52wk High
77.700
Shares
51.70M
P/E(Static)
Loss
52wk Low
13.600
Float Cap
739.15M
Bid/Ask %
-93.33%
Historical High
96.480
Shs Float
26.31M
Volume Ratio
0.57
Historical Low
13.600
Dividend TTM
--
Div Yield TTM
--
P/B
4.46
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.98%
Amplitude
3.97%
Avg Price
28.060
Lot Size
1
Float Cap
739.15M
Bid/Ask %
-93.33%
Historical High
96.480
Shs Float
26.31M
Volume Ratio
0.57
Historical Low
13.600
Dividend TTM
--
P/B
4.46
Dividend LFY
--
Turnover Ratio
1.98%
Amplitude
3.97%
Avg Price
28.060
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in applying a precision medicine approach to acquiring, developing and commercializing medicines. It focuses on developing drugs for underserved patient populations suffering from devastating rare diseases and cancer. Its pipeline include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
CEO: Mr. Saqib Islam, J.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...